Articles

• Head-shaking nystagmus in lateral medullary infarctionPatterns and possible mechanisms

  K. -D. Choi, S. -Y. Oh, S. -H. Park, J. -H. Kim, J. -W. Koo, J. S. Kim

  • Abstract
  • Full Text
  • Full Text (PDF)
• Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?

  P. -P. Derost, L. Ouchchane, D. Morand, M. Ulla, P. -M. Llorca, M. Barget, B. Debilly, J. -J. Lemaire, F. Durif

  • Abstract
  • Full Text
  • Full Text (PDF)
• Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

  Roger Kurlan, Jeffrey Cummings, Rema Raman, Leon Thal

  • Abstract
  • Full Text
  • Full Text (PDF)
• Recanalization after intravenous thrombolysisDoes a recanalization time window exist?

  M. T. Wunderlich, M. Goertler, T. Postert, E. Schmitt, G. Seidel, G. Gahn, C. Samii, E. Stolz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora

  P. Gómez-Garre, E. Gutiérrez-Delicado, C. Gómez-Abad, J. Morales-Corraliza, V. E. Villanueva, S. Rodríguez de Córdoba, J. Larrauri, M. Gutiérrez, J. Berciano, J. M. Serratosa

  • Abstract
  • Full Text
  • Full Text (PDF)
• New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p

  R. Nabbout, S. Baulac, I. Desguerre, N. Bahi-Buisson, C. Chiron, M. Ruberg, O. Dulac, E. LeGuern

  • Abstract
  • Full Text
  • Full Text (PDF)
• FAME 3A novel form of progressive myoclonus and epilepsy

  J. A. Carr, P. E. van der Walt, J. Nakayama, Y. -H. Fu, V. Corfield, P. Brink, L. Ptacek

  • Abstract
  • Full Text
  • Full Text (PDF)
• MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS

  D. H. Miller, D. Soon, K. T. Fernando, D. G. MacManus, G. J. Barker, T. A. Yousry, E. Fisher, P. W. O'Connor, J. T. Phillips, C. H. Polman, L. Kappos, M. Hutchinson, E. Havrdova, F. D. Lublin, G. Giovannoni, A. Wajgt, R. Rudick, F. Lynn, M. A. Panzara, A. W. Sandrock

  • Abstract
  • Full Text
  • Full Text (PDF)
• Quantitative objective markers for upper and lower motor neuron dysfunction in ALS

  H. Mitsumoto, A. M. Uluğ, S. L. Pullman, C. L. Gooch, S. Chan, M. -X. Tang, X. Mao, A. P. Hays, A. G. Floyd, V. Battista, J. Montes, S. Hayes, S. Dashnaw, P. Kaufmann, P. H. Gordon, J. Hirsch, B. Levin, L. P. Rowland, D. C. Shungu

  • Abstract
  • Full Text
  • Full Text (PDF)
• Course of cerebral amyloid angiopathy–related inflammation

  C. Kinnecom, M. H. Lev, L. Wendell, E. E. Smith, J. Rosand, M. P. Frosch, S. M. Greenberg

  • Abstract
  • Full Text
  • Full Text (PDF)
• How migraines impact cognitive functionFindings from the Baltimore ECA

  A. Kalaydjian, P. P. Zandi, K. L. Swartz, W. W. Eaton, C. Lyketsos

  • Abstract
  • Full Text
  • Full Text (PDF)